Metoclopramide
Metoclopramide is an antiemetic and gastrointestinal prokinetic medicine used for the short-term management of nausea and vomiting, including symptoms associated with migraine, chemotherapy, or certain postoperative conditions. It works primarily by blocking dopamine D₂ receptors and enhancing upper gastrointestinal motility, thereby helping the stomach empty more efficiently. It is available as oral tablets, oral liquid, and injectable formulations. Common side effects include drowsiness, fatigue, restlessness, diarrhoea, and dizziness. Prolonged or high-dose use can cause serious movement disorders, including tardive dyskinesia, so treatment duration should generally be limited according to the approved product guidance. Metoclopramide should be used under medical supervision and avoided in patients with gastrointestinal obstruction, perforation, or bleeding, as well as in those with certain movement disorders.
Metoclopramide was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Metoclopramide, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Metoclopramide from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Metoclopramide, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
